Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Find a Doctor

John Koreth, MBBS, DPhil

Medical Oncology

 Make an Appointment
Watch Video

John Koreth, MBBS, DPhil

Physician

  • Director of Translational Research, Stem Cell Transplantation
  • Institute Physician
  • Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Leukemias
  • Lymphoma
  • Multiple myeloma
  • Myelodysplasia
  • Stem cell/bone marrow transplant

Diseases Treated

  • Allogeneic Stem Cell Transplant

Contact Information

  • Appointments617-632-5138 (new)
    617-632-3470 (follow-up)
  • Office Phone Number617-632-3470
  • Fax617-632-5168
Make an Appointment

Bio

Dr. Koreth received his MD from the University of Delhi, India, in 1993. After receiving his PhD from Oxford University, he completed his postgraduate training at Brigham & Women's Hospital, followed by fellowships in Hematology/Oncology at DFCI, BWH, and MGH. In 2004, he joined DFCI, and is currently a member of the Hematologic Malignancies staff.

Board Certification:

  • Hematology, 2005
  • Internal Medicine, 2001
  • Medical Oncology, 2004

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology/Oncology
  • Saint Cross College, Oxford University

Residency:

  • Brigham and Women's Hospital, Internal Medicine
  • G.B. Pant Hospital, M.A.M. College, New Delhi, Pathology
  • G.B. Pant Hospital, M.A.M. College, New Delhi, Psychiatry

Medical School:

  • Maulana Azad Medical College, University of Delhi

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

  • Publications
    2/22/2023

    An ongoing commitment to research and innovation has transformed the lives of thousands of patients

    • Immunotherapy
    • Stem Cell/Bone Marrow Transplant
    • Lymphomas
    • Leukemias
    Publications
    4/8/2022

    Dana-Farber's Role in the Worldwide Effort to End the Most Common Side Effect of Stem Cell Transplant

    • Research
    • Stem Cell/Bone Marrow Transplant, Childhood
    • Stem Cell/Bone Marrow Transplant
    John Koreth, MBBS, DPhil
    News Releases
    12/10/2017

    Low-dose treatment with interleukin-2 across multiple studies shows benefits in chronic graft-versus-host disease

    • Research
    News Releases
    12/10/2013

    Experimental treatment for graft-vs.-host disease may reduce steroid need

    • Research
    • Stem Cell/Bone Marrow Transplant
    News Releases
    12/8/2013

    Novel drug regimen can improve stem cell transplantation outcomes

    • Research
    • Stem Cell/Bone Marrow Transplant
    News Releases
    6/24/2013

    Study sets guidelines for stem cell transplants in older patients with myelodysplastic syndromes

    • Stem Cell/Bone Marrow Transplant
    • Myelodysplastic/Myeloproliferative Diseases
    News Releases
    4/11/2013

    Study illuminates biology behind promising therapy for graft-versus-host disease

    • Research
    • Stem Cell/Bone Marrow Transplant
Top